Pricing Log in Create free account

BioStem Technologies, Inc. (BSEM) vs Prima BioMed Ltd (IMMP)

BioStem Technologies, Inc. and Prima BioMed Ltd are both Biotechnology companies. BioStem Technologies, Inc. and Prima BioMed Ltd are of similar size ($19.8M and $19.4M). Across the 7 metrics below, BioStem Technologies, Inc. leads on 4 and Prima BioMed Ltd on 3.

Valuation

Metric BSEM IMMP Biotechnology median
P/E n/m — 10.60
P/S 0.56 n/m 9.40
P/B 0.70 0.05 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.68 n/m 0.66
EV/Sales 0.36 n/m 9.02
Earnings yield (137.92%) — (32.88%)
Free cash flow yield 0.00% (1,225.42%) (23.13%)

Profitability

Metric BSEM IMMP Biotechnology median
Gross margin 91.16% — 68.51%
Operating margin 52.87% — 0.00%
Net margin (76.02%) — 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (51.96%)
Return on assets 0.00% 0.00% (46.06%)
Return on invested capital 55.34% 0.00% 0.00%

Growth

Metric BSEM IMMP Biotechnology median
Revenue growth (TTM) (87.14%) — 6.76%
EPS growth (last fiscal year) (126.53%) 93.23% 29.88%
Revenue growth, 5-year CAGR — 40.79% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BSEM IMMP Biotechnology median
Debt to equity 0.00 0.01 0.00
Current ratio 0.98 2.97 4.97
Net debt to EBITDA 0.00 0.92 1.01

Dividend

Metric BSEM IMMP Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BSEM IMMP Biotechnology median
Market cap 19.42m 19.83m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack